PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.86%
Revenue growth above 1.5x ADI's 3.41%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
0.99%
Gross profit growth under 50% of ADI's 4.35%. Michael Burry would be concerned about a severe competitive disadvantage.
3232.57%
EBIT growth above 1.5x ADI's 9.30%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
3232.57%
Operating income growth above 1.5x ADI's 9.30%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-8.90%
Negative net income growth while ADI stands at 15.57%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-2.50%
Negative EPS growth while ADI is at 15.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-10.00%
Negative diluted EPS growth while ADI is at 15.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-18.38%
Share reduction while ADI is at 0.17%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
16.37%
Diluted share count expanding well above ADI's 0.17%. Michael Burry would fear significant dilution to existing owners' stakes.
-9.44%
Dividend reduction while ADI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
36.22%
OCF growth under 50% of ADI's 91.53%. Michael Burry might suspect questionable revenue recognition or rising costs.
88.24%
FCF growth under 50% of ADI's 1185.71%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
106.37%
10Y revenue/share CAGR 1.25-1.5x ADI's 90.62%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
57.31%
5Y revenue/share CAGR 1.25-1.5x ADI's 39.68%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
53.45%
3Y revenue/share CAGR above 1.5x ADI's 18.47%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-22.10%
Negative 3Y OCF/share CAGR while ADI stands at 104.84%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
440.05%
10Y net income/share CAGR of 440.05% while ADI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
56.48%
Net income/share CAGR of 56.48% while ADI is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
370.04%
3Y net income/share CAGR above 1.5x ADI's 154.77%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
70.39%
10Y equity/share CAGR 1.25-1.5x ADI's 52.25%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
50.67%
5Y equity/share CAGR above 1.5x ADI's 13.72%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
11.63%
3Y equity/share CAGR at 50-75% of ADI's 15.55%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
-29.09%
Cut dividends over 10 years while ADI stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
31.31%
Dividend/share CAGR of 31.31% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-15.96%
Negative near-term dividend growth while ADI invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
3.13%
AR growth is negative/stable vs. ADI's 15.45%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-7.95%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.04%
Negative asset growth while ADI invests at 6.57%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
23.65%
BV/share growth above 1.5x ADI's 3.50%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-1.95%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
6.65%
SG&A growth well above ADI's 2.33%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.